Faculty

Institution

Unit

Venue

Ehab L. Atallah MD

Professor

Medical College of Wisconsin

Affiliations

Faculty Collaboration Database

Ehab L. Atallah Md is currently serving as a Faculty Collaboration Database Professor at Medical College of Wisconsin.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Ehab L. Atallah MD

Medical College of Wisconsin

Professor

You can click a keyword to filter the displayed items

medicine hematology oncology leukemia hematological malignancies myeloid neoplasia pharmacology pharmacotherapy cancer care cancer research pathology chronic myeloid leukemia immunology cancer treatment clinical research bone marrow transplantation therapeutic targets outcomes research cell transplantation medicinal research lymphoid neoplasia oncogenes immunotherapy stem cell transplantation clinical transplantation malignant blood disorders molecular medicine cellular therapy therapeutic efficacy transplantation medicine treatment options tyrosine kinase inhibitors myelodysplastic syndromes acute myeloid leukemia thrombosis cancer management novel therapies cell therapy united states surgical oncology aplastic anemia anti-cancer agents cardiovascular research clinical therapeutics treatment development transplant surgery stem-cell therapy patient support chronic myelomonocytic leukemia high-risk myelodysplastic syndromes older patients real-world outcomes inotuzumab ozogamicin cardiovascular interventions supportive care laboratory medicine respiratory medicine cardiac care structural heart disease cardiomyopathy melanoma skin cancer eosinophilic disorders myelopoiesis tumor targeting therapy resistance cancer biology prospective cohort studies cross-sectional studies disease management imatinib therapy rare event congestive heart failure higher-risk myelodysplastic syndromes azacitidine alone metastatic malignant melanoma janus kinases bone marrow transplant

Notable Scholarly Works

Notable Federal Grants

Collaborators

40 is the New 50: Reducing the Need for Platelet Transfusions Prior to Lumbar Puncture in Adults With Hematologic Malignancies.. Haematologica (2025)

medicineblood platelethematologythrombosishematologic malignanciesplatelet transfusionsnew 50bone marrow transplantationclinical researchcritical caretransfusion medicineblood transfusionhemostasis

Advanced-Stage Chronic Myeloid Leukemia: Options for Difficult Treatment Situations. Blood (2025)

hematological malignanciesmedicineleukemiamyeloid neoplasiahematologydifficult treatment situationsoncology

Phase 1 Study of Lintuzumab-Ac225 Combined With Clag-M Salvage Therapy in Relapsed/Refractory Acute Myeloid Leukemia. Leukemia (2025)

Sameem M. AbedinGuru Subramanian Guru MurthyMehdi HamadaniLaura C. MichaelisKaren-Sue CarlsonLyndsey RunaasKatelyn GaugerAvinash G. DesaiMary M. ChenKate L. LiMojisola RotibiUmar SyedMadhuri VusirikalaAlexandra HarringtonEhab L. Atallah

hematological malignanciesmedicineleukemiamyeloid neoplasiahematologytreatment developmentcancer researchoncologyclinical researchbone marrow transplantationclag-m salvage therapycancer treatment

Real-World Evaluation of Treatment Patterns and Clinical Outcomes Among Patients With Chronic Myeloid Leukemia in Chronic Phase Treated With Asciminib in Clinical Practice in the United States: Real-World Asciminib Treatment Outcomes in CML-Cp. Clin Lymphoma Myeloma Leuk (2025)

hematological malignanciesmedicineoutcomes researchleukemiacancer caremyeloid neoplasiahematologychronic myeloid leukemiaclinical outcomestreatment plan evaluationoncologytreatment patternshealth policy

Tyrosine Kinase Inhibitor Discontinuation and Reinitiation Patterns in CML Patients in the Us: Real-World Evidence. Leukemia & lymphoma/Leukemia and lymphoma (2025)

Jyotirmoy SarkerEhab L. AtallahKathryn E. FlynnAaron N. Winn

hematological malignanciesmedicineleukemiacml patientsreal world evidencereinitiation patternshematologylymphoid neoplasiamalignant blood disorders

An Emt-Like Signature as a Potential Driver of Myeloid Sarcoma.. Blood Neoplasia (2024)

hematological malignanciesleukemiamyeloid neoplasiaradiation oncologyoncologysarcomatumor microenvironmentsurgical pathologypathologytumor biologyemt-like signature

A Phase 1 Trial of Venetoclax in Combination With Liposomal Vincristine in Patients With Relapsed or Refractory B-Cell or T-Cell Acute Lymphoblastic Leukemia: Results From the Ecog-Acrin Ea9152 Protocol. Blood (2024)

immunologyhematological malignanciesliposomal vincristineleukemiaphase 1ecog-acrin ea9152 protocolhematologyradiation oncologylymphoid neoplasiapharmacotherapyoncologymalignant blood disorderscellular therapy

A Phase I Study of Pevonedistat, Azacitidine, and Venetoclax in Patients With Relapsed/Refractory Acute Myeloid Leukemia. (2024)

hematological malignanciesmedicineleukemiapharmacologymyeloid neoplasiahematologypharmacotherapymixed-phenotype acute leukemiaoncology

A Phase I Study of Pevonedistat, Azacitidine, and Venetoclax in Patients With Relapsed/Refractory Acute Myeloid Leukemia.. Haematologica (2024)

hematological malignanciesmedicineleukemiapharmacologymyeloid neoplasiahematologycancer researchpharmacotherapyoncologyclinical research

1
2
3
4
5
13
10 / page

Ehab L. Atallah MD

Professor

Medical College of Wisconsin

Affiliations

Faculty Collaboration Database

Ehab L. Atallah Md is currently serving as a Faculty Collaboration Database Professor at Medical College of Wisconsin.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Ehab L. Atallah MD

Medical College of Wisconsin

Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

40 is the New 50: Reducing the Need for Platelet Transfusions Prior to Lumbar Puncture in Adults With Hematologic Malignancies.. Haematologica (2025)

medicineblood platelethematologythrombosishematologic malignanciesplatelet transfusionsnew 50bone marrow transplantationclinical researchcritical caretransfusion medicineblood transfusionhemostasis

Advanced-Stage Chronic Myeloid Leukemia: Options for Difficult Treatment Situations. Blood (2025)

hematological malignanciesmedicineleukemiamyeloid neoplasiahematologydifficult treatment situationsoncology

Phase 1 Study of Lintuzumab-Ac225 Combined With Clag-M Salvage Therapy in Relapsed/Refractory Acute Myeloid Leukemia. Leukemia (2025)

hematological malignanciesmedicineleukemiamyeloid neoplasiahematologytreatment developmentcancer researchoncologyclinical researchbone marrow transplantationclag-m salvage therapycancer treatment

Tyrosine Kinase Inhibitor Discontinuation and Reinitiation Patterns in CML Patients in the Us: Real-World Evidence. Leukemia & lymphoma/Leukemia and lymphoma (2025)

Jyotirmoy SarkerEhab L. AtallahKathryn E. FlynnAaron N. Winn

hematological malignanciesmedicineleukemiacml patientsreal world evidencereinitiation patternshematologylymphoid neoplasiamalignant blood disorders

An Emt-Like Signature as a Potential Driver of Myeloid Sarcoma.. Blood Neoplasia (2024)

hematological malignanciesleukemiamyeloid neoplasiaradiation oncologyoncologysarcomatumor microenvironmentsurgical pathologypathologytumor biologyemt-like signature

A Phase I Study of Pevonedistat, Azacitidine, and Venetoclax in Patients With Relapsed/Refractory Acute Myeloid Leukemia. (2024)

hematological malignanciesmedicineleukemiapharmacologymyeloid neoplasiahematologypharmacotherapymixed-phenotype acute leukemiaoncology

A Phase I Study of Pevonedistat, Azacitidine, and Venetoclax in Patients With Relapsed/Refractory Acute Myeloid Leukemia.. Haematologica (2024)

hematological malignanciesmedicineleukemiapharmacologymyeloid neoplasiahematologycancer researchpharmacotherapyoncologyclinical research

1
2
3
4
5
13
10 / page

Similar Faculty Members

Sarah Holstein

Institution

University of Nebraska Medical Center

multiple myeloma

hematological malignancies

Veronika Bachanova

Institution

University of Minnesota

phase 1

clinical trial

Anand Jillella

Institution

Augusta University

hematology

medicine

Jonathan E Brammer

Institution

Ohio State University

applied artificial intelligence

multidisciplinary ai

Li Zhang

Institution

University of California, San Francisco

cancer letter

pathology

Anita D'Souza

Institution

Medical College of Wisconsin

psychiatry

hematology

Nirav N. Shah, MD

Institution

Medical College of Wisconsin

cellular therapy

hematology

Markus Mapara

Institution

Columbia University

immunotherapy

immunology

Vivian Oehler

Institution

University of Washington

pathology

gene expression

Aniko Szabo

Institution

Medical College of Wisconsin

prostate cancer incidence

microarray data analysis

Similar Faculty Members

Sarah Holstein

Institution

University of Nebraska Medical Center

multiple myeloma

hematological malignancies

Veronika Bachanova

Institution

University of Minnesota

phase 1

clinical trial

Anand Jillella

Institution

Augusta University

hematology

medicine

Jonathan E Brammer

Institution

Ohio State University

applied artificial intelligence

multidisciplinary ai

Li Zhang

Institution

University of California, San Francisco

cancer letter

pathology

Anita D'Souza

Institution

Medical College of Wisconsin

psychiatry

hematology

Nirav N. Shah, MD

Institution

Medical College of Wisconsin

cellular therapy

hematology

Markus Mapara

Institution

Columbia University

immunotherapy

immunology

Vivian Oehler

Institution

University of Washington

pathology

gene expression

Aniko Szabo

Institution

Medical College of Wisconsin

prostate cancer incidence

microarray data analysis